No Data
No Data
Garden Convertible Bonds: The conversion price was adjusted from 15.05 yuan/share to 13.56 yuan/share
Zhejiang Huayuan Biomedical Co., Ltd. announced that the conversion price of “Huayuan Bonds” was adjusted from 15.05 yuan/share to 13.56 yuan/share. The implementation date of this share transfer price adjustment is May 17, 2024.
Garden Convertible Bonds: The registration period for the resale is from May 20 to May 24
Zhejiang Huayuan Biomedical Co., Ltd. announced that the registration period for the resale of “Huayuan Bonds” is from May 20, 2024 to May 24, 2024, and the repurchase transfer date is May 30, 2024.
Garden Biology (300401.SZ): In the future, we will unswervingly promote the dual layout of “chemical synthesis and biosynthesis”
Gelonghui, May 9, 丨 Garden Biology (300401.SZ) said on the investor interactive platform that the company's existing products mainly use chemical synthesis. In the future, the company will unswervingly promote the dual layout of “chemical synthesis and biosynthesis”. Currently, it has invested abroad to establish a joint venture “Zhejiang Garden Biotechnology Co., Ltd.” to increase the company's market and technology development efforts in the field of amino acid and vitamin biosynthesis. At the same time, the company plans to invest in the construction of a “pilot base project with an annual output of 10,000 tons of L-alanine (fermentation method) and biological manufacturing”, which uses advanced biological manufacturing methods.
Garden Biotech (300401.SZ) 2023 equity distribution: $0.71 for every 10 shares, shares registered on May 14
According to the Zhitong Finance App, Huayuan Biotech (300401.SZ) announced that the company's 2023 equity distribution plan is to distribute a cash dividend of 0.71 yuan to all shareholders for every 10 shares based on the total share capital on the registration date of the company's equity distribution. The share registration date for this equity distribution is: May 14, 2024, and the excluding dividend date is: May 15, 2024.
Express News | Garden Biology: It has invested abroad to establish a joint venture to increase market and technology development in the field of amino acid and vitamin biosynthesis
Garden Convertible Bonds: The first bondholders' meeting in 2024 reviewed and passed the relevant bill
Zhejiang Huayuan Biomedical Co., Ltd. announced that the first “Huayuan Bonds” 2024 bondholders' meeting has been held. The meeting reviewed and passed the “Proposal on Adjusting the Use of Fund-raising Projects and Adding New Fund-raising Projects”.
No Data